Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page
- Check8 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics to the Related Topics section.SummaryDifference0.2%

- Check15 days agoChange DetectedMelanoma and related topics, including MedlinePlus Genetics, were removed from the page.SummaryDifference0.2%

- Check23 days agoChange DetectedAdded related topics Melanoma and MedlinePlus Genetics to the study page. The revision tag was updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check30 days agoChange DetectedAdded Revision: v3.4.3; Melanoma and related topics (including MedlinePlus Genetics) and Revision: v3.4.2 have been removed.SummaryDifference0.2%

- Check44 days agoChange DetectedDeleted the related topics entries 'Melanoma' and 'MedlinePlus Genetics'. This update alters the related topics listing but does not affect the study content or eligibility information.SummaryDifference0.2%

- Check58 days agoChange DetectedAdded Melanoma as a related topic and MedlinePlus Genetics; updated page revision to v3.4.2. Removed the funding-status notice and the previous Revision: v3.4.1.SummaryDifference0.6%

Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.